Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05330312 · ClinicalTrials.gov registry record · NA
Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF
A NA study, sponsored by Vicore Pharma AB.
- Completed
- Registry status
- NA
- Development phase
- 119
- Enrollment target
NCT05330312 is a NA study that has completed, run by Vicore Pharma AB. The registered enrollment target is 119 participants.
The verdict
NCT05330312, a NA study, has completed, sponsored by Vicore Pharma AB.
- COMPLETED
- Registry status
- NA
- Development phase
- 119 participants
- Enrollment target
Study Summary
The purpose of the study is to assess efficacy and safety of a digital cognitive behavioural therapy for patients with pulmonary fibrosis on anxiety.
Interventions
- DEVICE Digital cognitive behavioral therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2022-04-17 |
| Est. Completion | 2023-11-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05330312
The ClinicalTrials.gov registry entry for NCT05330312 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vicore Pharma AB, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Digital cognitive behavioral therapy is the first listed.
NCT05330312 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05330312 about?
NCT05330312 is a clinical study titled "Controlled Investigation to Evaluate Impact of dCBT on Psychological Symptom Burden in Adult Subjects With PF". The purpose of the study is to assess efficacy and safety of a digital cognitive behavioural therapy for patients with pulmonary fibrosis on anxiety.
What is the current status of trial NCT05330312?
This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2022-04-17. Estimated completion is 2023-11-10.
What interventions are being tested in trial NCT05330312?
The interventions under investigation include: Digital cognitive behavioral therapy (DEVICE).
Who is sponsoring clinical trial NCT05330312?
This trial is sponsored by Vicore Pharma AB, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.